In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease-Reference-Cited by-同舟云学术

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease

Published:2022-01 Issue:1 Volume:13 Page:100413
ISSN:0975-9476
Container-title:Journal of Ayurveda and Integrative Medicine
language:en
Short-container-title:Journal of Ayurveda and Integrative Medicine

Author:

Ram Thrigulla Saketh^ORCID,Munikumar Manne^ORCID,Raju Vankudavath Naik^ORCID,Devaraj Parasannanavar,Boiroju Naveen Kumar,Hemalatha Rajkumar,Prasad P.V.V.,Gundeti Manohar^ORCID,Sisodia Brijesh S.,Pawar Sharad,Prasad G.P.,Chincholikar Mukesh,Goel Sumeet^ORCID,Mangal Anupam,Gaidhani Sudesh,Srikanth N.,Dhiman K.S.

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery

Reference72 articles.

1. Sars-cov-2 and coronavirus disease 2019: what we know so far;Rabi;Pathogens,2020

2. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020

3. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

4. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

5. Coronavirus main proteinase (3CLpro) Structure: basis for design of anti-SARS drugs;Anand;Science (80- ),2003

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19, its prevention and treatment in the light of Ayush medicines;Pharmacological Research - Natural Products;2024-06

2. Effect of Yoga-based breathing practices on depression, anxiety, stress, and fear of COVID-19 positive hospitalized patients: A randomized controlled trial;Journal of Ayurveda and Integrative Medicine;2024-03

3. Need and Possibilities of Phytocompounds against SARS-CoV-2: Recent Advances in COVID-19 Therapy;Current Traditional Medicine;2024-02

4. Evaluating therapeutic potential of AYUSH-64 constituents against omicron variant of SARS-CoV-2 using ensemble docking and simulations;Current Research in Structural Biology;2024

5. Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules;Applied Biological Chemistry;2023-12-13